ATWOOD BRIAN G
Insider CIK 1266567 · FPRX Director · GKOS 10% owner · OPGN,OPGNW Director, 10% owner · INGN 10% owner · CADX Director · TSRX Director · VCYT Director, 10% owner · FLXN Director, 10% owner · PZRX Director, 10% owner · IMDZ Director, 10% owner · CLVS Director, 10% owner · BCEL Director · LWAC Director · PBAX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2026-01-07 | 2026-01-09 | 1,612,099 | — | $0 | 1,612,099 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-05-30 | 2025-06-02 | 122,549 | — | $0 | 122,549 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | M Exercise deriv | 2025-03-31 | 2025-04-04 | 294,460 | — | $0 | 11,660 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | M Exercise | 2025-03-31 | 2025-04-04 | 294,460 | — | $0 | 490,534 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-03-04 | 2025-03-06 | 14,936 | — | $0 | 14,936 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-02-24 | 2025-02-26 | 254,000 | — | $0 | 508,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-02-07 | 2025-02-07 | 204,080 | — | $0 | 204,080 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-02-07 | 2025-02-07 | 306,120 | $1.96 | $600.0K | 306,120 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-02-07 | 2025-02-07 | 204,080 | $1.96 | $400.0K | 204,080 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-02-07 | 2025-02-07 | 306,120 | — | $0 | 306,120 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-12-02 | 2024-12-04 | 254,000 | — | $0 | 254,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | D To issuer deriv | 2024-09-30 | 2024-10-02 | 1,317,956 | — | $0 | 0 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | D To issuer deriv | 2024-09-30 | 2024-10-02 | 13,857 | — | $0 | 0 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | M Exercise deriv | 2024-09-25 | 2024-10-02 | 1,002 | $1000.00 | $1.00M | 0 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | M Exercise | 2024-09-25 | 2024-10-02 | 19,358,578 | — | $0 | 19,607,313 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-03-25 | 2024-03-27 | 1,317,956 | — | $0 | 1,317,956 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-02-14 | 2024-02-16 | 1,002 | $1000.00 | $1.00M | 1,002 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-02-14 | 2024-02-21 | 1,002 | $1000.00 | $1.00M | 1,002 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-02-14 | 2024-03-11 | 1,002 | $1000.00 | $1.00M | 1,002 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-02-14 | 2024-03-11 | 13,857 | — | $0 | 13,857 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-16 | 148,208 | — | $0 | 248,735 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-16 | 100,527 | — | $0 | 100,527 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-16 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-21 | 148,208 | — | $0 | 248,735 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-21 | 100,527 | — | $0 | 100,527 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-03-11 | 148,208 | — | $0 | 248,735 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-03-11 | 100,527 | — | $0 | 100,527 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-08 | 2022-06-13 | 12,000 | — | $0 | 12,000 | SEC↗ |
| PBAX PHOENIX BIOTECH ACQUISITIO | J Other deriv | 2021-10-08 | 2021-10-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 42,223 | — | $0 | 42,223 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2021-06-09 | 2021-06-11 | 12,000 | — | $0 | 12,000 | SEC↗ |
| LWAC Locust Walk Acquisition Co | J Other deriv | 2021-01-12 | 2021-01-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BCEL Atreca, Inc. | G Gift deriv | 2020-12-09 | 2020-12-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BCEL Atreca, Inc. | G Gift deriv | 2020-12-09 | 2020-12-10 | 12,000 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | G Gift deriv | 2020-12-09 | 2020-12-10 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BCEL Atreca, Inc. | G Gift deriv | 2020-12-09 | 2020-12-10 | 12,500 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | G Gift deriv | 2020-12-09 | 2020-12-10 | 34,166 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | G Gift deriv | 2020-12-09 | 2020-12-10 | 34,166 | — | $0 | 34,166 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-11-09 | 2020-11-10 | 6,896 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-11-09 | 2020-11-10 | 6,896 | $3.08 | $21.2K | 32,758 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2020-06-10 | 2020-06-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2020-06-04 | 2020-06-05 | 40,138 | — | $0 | 40,138 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-08-20 | 2019-08-22 | 25,862 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-08-20 | 2019-08-22 | 25,862 | $0.29 | $7.5K | 25,862 | SEC↗ |
| BCEL Atreca, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-24 | 4,504 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-24 | 4,287 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | C Conversion | 2019-06-24 | 2019-06-24 | 8,791 | — | $0 | 49,654 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-06-06 | 2019-06-07 | 28,882 | — | $0 | 2,882 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-10-11 | 2018-10-15 | 14,770 | — | $0 | 14,770 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-06-26 | 2017-06-28 | 4,998 | — | $0 | 25,577 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2017-06-26 | 2017-06-28 | 212 | — | $0 | 20,579 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-06-08 | 2017-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PZRX PHASERX, INC. | A Award deriv | 2017-05-25 | 2017-05-30 | 14,000 | — | $0 | 14,000 | SEC↗ |
| OPGN OPGEN INC | A Award deriv | 2016-06-22 | 2016-06-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VCYT VERACYTE, INC. | A Award deriv | 2016-06-20 | 2016-06-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-06-09 | 2016-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2016-06-08 | 2016-06-10 | 710,091 | $14.00 | $9.94M | 3,511,670 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2016-06-08 | 2016-06-10 | 4,194 | $14.00 | $58.7K | 20,739 | SEC↗ |
| PZRX PHASERX, INC. | A Award deriv | 2016-06-01 | 2016-06-03 | 28,203 | — | $0 | 28,203 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 397 | — | $0 | 397 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 2,317 | — | $0 | 2,317 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 397 | — | $0 | 397 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 989 | — | $0 | 989 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 989 | — | $0 | 989 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 741 | — | $0 | 741 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 496 | — | $0 | 496 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 128,758 | — | $0 | 128,758 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-05-31 | 2016-06-02 | 23,088 | $23.98 | $553.7K | 109,395 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-05-31 | 2016-06-02 | 10,970 | $23.98 | $263.1K | 51,247 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 9,892 | — | $0 | 46,804 | SEC↗ |
| GKOS GLAUKOS Corp | J Other | 2016-05-31 | 2016-06-02 | 505,297 | — | $0 | 2,379,539 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 435 | $0.01 | $4 | 8,965 | SEC↗ |
| PZRX PHASERX, INC. | P Buy | 2016-05-23 | 2016-05-24 | 3,523 | $5.00 | $17.6K | 11,408 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 73,615 | $0.01 | $736 | 1,517,531 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 182,914 | $0.01 | $1.8K | 1,334,617 | SEC↗ |
| PZRX PHASERX, INC. | P Buy | 2016-05-23 | 2016-05-24 | 596,477 | $5.00 | $2.98M | 1,931,094 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 1,080 | $0.01 | $11 | 7,885 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 435 | $0.01 | $4 | 8,965 | SEC↗ |
| PZRX PHASERX, INC. | P Buy | 2016-05-23 | 2016-05-24 | 596,477 | $5.00 | $2.98M | 1,931,094 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 1,080 | $0.01 | $11 | 7,885 | SEC↗ |
| PZRX PHASERX, INC. | P Buy | 2016-05-23 | 2016-05-24 | 3,523 | $5.00 | $17.6K | 11,408 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 73,615 | $0.01 | $736 | 1,517,531 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 182,914 | $0.01 | $1.8K | 1,334,617 | SEC↗ |
| IMDZ Immune Design Corp. | A Award deriv | 2016-01-04 | 2016-01-06 | 9,300 | — | $0 | 9,300 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 12,000 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 1,296 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 577 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 27,612 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 5,465 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 12,840 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 5,715 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 273,337 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 3,271 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 7,684 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 3,420 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 163,592 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 10,791 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 25,226 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 11,805 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 548,464 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 9,386 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 21,900 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 10,428 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 479,714 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 16,666 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 38,888 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 18,518 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 851,852 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 10,800 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 25,200 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 552 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 552,000 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 552 | — | $0 | 56,931 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 56,379 | — | $0 | 56,379 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 551 | $18.00 | $9.9K | 132,483 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 1,296 | — | $0 | 133,034 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 235 | $18.00 | $4.2K | 56,696 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 131,738 | — | $0 | 131,738 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 246 | $18.00 | $4.4K | 62,217 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 577 | — | $0 | 62,463 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 61,886 | — | $0 | 61,886 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 11,736 | $18.00 | $211.2K | 2,884,835 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 27,612 | — | $0 | 2,896,571 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 2,868,959 | — | $0 | 2,868,959 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2015-06-12 | 2015-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2015-06-11 | 2015-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VCYT VERACYTE, INC. | A Award deriv | 2015-05-19 | 2015-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-18 | 91,279 | — | $0 | 91,279 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-18 | 404,867 | — | $0 | 404,866 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-18 | 91,279 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-18 | 2,550 | — | $0 | 2,550 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-18 | 283 | — | $0 | 13,638 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2015-05-14 | 2015-05-18 | 6,729 | — | $0 | 20,367 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion deriv | 2015-05-08 | 2015-05-12 | 404,725 | — | $0 | 0 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion deriv | 2015-05-08 | 2015-05-12 | 503,522 | — | $0 | 0 | SEC↗ |
| OPGN,OPGNW OPGEN INC | P Buy deriv | 2015-05-08 | 2015-05-12 | 413,332 | — | $0 | 413,332 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion deriv | 2015-05-08 | 2015-05-12 | 1,160,039 | — | $0 | 0 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion | 2015-05-08 | 2015-05-12 | 1,160,039 | — | $0 | 1,645,964 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion | 2015-05-08 | 2015-05-12 | 404,725 | — | $0 | 2,050,689 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion | 2015-05-08 | 2015-05-12 | 503,522 | — | $0 | 2,554,211 | SEC↗ |
| OPGN,OPGNW OPGEN INC | P Buy | 2015-05-08 | 2015-05-12 | 413,332 | $6.00 | $2.48M | 485,925 | SEC↗ |
| IMDZ Immune Design Corp. | A Award deriv | 2015-01-07 | 2015-01-09 | 9,300 | — | $0 | 9,300 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 17,832 | — | $0 | 56,127 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 17,832 | — | $0 | 54,163 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 136,039 | — | $0 | 0 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 17,832 | — | $0 | 56,385 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 17,832 | — | $0 | 56,385 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-07 | 2015-01-08 | 4,459 | — | $0 | 16,329 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 778 | — | $0 | 54,941 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 136,039 | — | $0 | 136,039 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 778,272 | — | $0 | 1,263,716 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 389 | — | $0 | 56,516 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 486 | — | $0 | 56,871 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 486 | — | $0 | 56,871 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 6,952 | — | $0 | 7,812 | SEC↗ |
| INGN Inogen Inc | J Other | 2015-01-06 | 2015-01-08 | 972 | — | $0 | 17,301 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 60,344 | — | $0 | 0 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 1,126 | — | $0 | 60,344 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 59,218 | — | $0 | 59,218 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 486,420 | — | $0 | 2,041,988 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 4,345 | — | $0 | 14,764 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 9,235 | — | $0 | 31,334 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 607 | — | $0 | 11,870 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 305 | — | $0 | 38,553 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 7,944 | — | $0 | 38,248 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 305 | — | $0 | 38,553 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 7,944 | — | $0 | 38,248 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 244 | — | $0 | 38,295 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 7,942 | — | $0 | 38,051 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 488 | — | $0 | 36,331 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 7,950 | — | $0 | 35,843 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2015-01-05 | 1,986 | — | $0 | 11,263 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 7,944 | — | $0 | 38,248 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 9,235 | — | $0 | 31,334 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 4,345 | — | $0 | 14,764 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 486,420 | — | $0 | 2,041,988 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 59,218 | — | $0 | 59,218 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 1,126 | — | $0 | 60,344 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 60,344 | — | $0 | 0 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 7,950 | — | $0 | 35,843 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 488 | — | $0 | 36,331 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 7,942 | — | $0 | 38,051 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 244 | — | $0 | 38,295 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 305 | — | $0 | 38,553 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 607 | — | $0 | 11,870 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 1,986 | — | $0 | 11,263 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 305 | — | $0 | 38,553 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-12-18 | 2014-12-22 | 7,944 | — | $0 | 38,248 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-17 | 2014-11-19 | 5,343 | $24.89 | $133.0K | 40,569 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-14 | 2014-11-14 | 3,928 | $25.06 | $98.4K | 45,912 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-13 | 2014-11-14 | 5,505 | $25.18 | $138.6K | 49,840 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 14,929 | — | $0 | 29,818 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 14,929 | — | $0 | 27,117 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 113,112 | — | $0 | 0 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 113,112 | — | $0 | 113,112 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 778,272 | — | $0 | 2,528,408 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 6,952 | — | $0 | 19,109 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 486 | — | $0 | 30,304 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 14,929 | — | $0 | 29,818 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 388 | — | $0 | 30,109 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 486 | — | $0 | 30,304 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 3,733 | — | $0 | 8,305 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 972 | — | $0 | 9,277 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 14,932 | — | $0 | 29,721 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-12 | 2014-11-14 | 776 | — | $0 | 27,893 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-10 | 2014-11-12 | 2,992 | $24.42 | $73.1K | 12,188 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-07 | 2015-05-11 | 3,150 | $23.95 | $75.4K | 55,345 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-07 | 2014-11-07 | 3,150 | $23.95 | $75.4K | 55,345 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-06 | 2015-05-11 | 4,238 | $24.56 | $104.1K | 58,495 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-11-06 | 2014-11-07 | 4,238 | $24.56 | $104.1K | 58,495 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 5,596 | — | $0 | 15,180 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 243 | — | $0 | 9,294 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 5,595 | — | $0 | 14,889 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 243 | — | $0 | 9,294 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 5,595 | — | $0 | 14,889 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 486 | — | $0 | 3,174 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 1,398 | — | $0 | 4,572 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 3,476 | — | $0 | 26,061 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 389,136 | — | $0 | 2,917,544 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 42,216 | — | $0 | 42,216 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 42,216 | — | $0 | 0 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 194 | — | $0 | 9,195 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 5,594 | — | $0 | 14,789 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2015-05-11 | 388 | — | $0 | 9,584 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 5,594 | — | $0 | 14,789 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 388 | — | $0 | 9,584 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 3,476 | — | $0 | 26,061 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 194 | — | $0 | 9,195 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 5,595 | — | $0 | 14,889 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 243 | — | $0 | 9,294 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 5,595 | — | $0 | 14,889 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 243 | — | $0 | 9,294 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 5,596 | — | $0 | 15,180 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 486 | — | $0 | 3,174 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-11-05 | 2014-11-07 | 1,398 | — | $0 | 4,572 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-10-24 | 2014-10-28 | 4,647 | $20.76 | $96.5K | 0 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-10-09 | 2014-10-14 | 1,756 | $20.83 | $36.6K | 0 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-10-09 | 2014-10-14 | 144 | $20.83 | $3.0K | 0 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-10-08 | 2014-10-09 | 525 | $21.03 | $11.0K | 144 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-10-08 | 2014-10-09 | 6,382 | $21.03 | $134.2K | 1,756 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-10-07 | 2014-10-09 | 669 | — | $0 | 669 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-10-07 | 2014-10-09 | 8,138 | — | $0 | 8,138 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-10-07 | 2014-10-09 | 2,202 | — | $0 | 2,688 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-10-07 | 2014-10-09 | 8,808 | — | $0 | 9,051 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-10-07 | 2014-10-09 | 8,808 | — | $0 | 9,051 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-10-07 | 2014-10-09 | 66,857 | — | $0 | 0 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-10-07 | 2014-10-09 | 8,807 | — | $0 | 9,001 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-10-07 | 2014-10-09 | 8,808 | — | $0 | 9,196 | SEC↗ |
| FLXN Flexion Therapeutics Inc | X Exercise deriv | 2014-09-10 | 2014-09-12 | 2,250 | — | $0 | 6,750 | SEC↗ |
| FLXN Flexion Therapeutics Inc | X Exercise | 2014-09-10 | 2014-09-12 | 2,250 | $17.61 | $39.6K | 2,250 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-09-09 | 2014-09-12 | 243 | — | $0 | 243 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-09-09 | 2014-09-12 | 243 | — | $0 | 243 | SEC↗ |
| INGN Inogen Inc | S Sale | 2014-09-09 | 2014-09-12 | 7,388 | $23.25 | $171.8K | 62,733 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-09-09 | 2014-09-12 | 3,476 | — | $0 | 29,537 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-09-09 | 2014-09-12 | 486 | — | $0 | 486 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-09-09 | 2014-09-12 | 243 | — | $0 | 243 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-09-09 | 2014-09-12 | 388 | — | $0 | 388 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-09-09 | 2014-09-12 | 194 | — | $0 | 194 | SEC↗ |
| INGN Inogen Inc | J Other | 2014-09-09 | 2014-09-12 | 389,136 | — | $0 | 3,306,680 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 531,840 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 733,941 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 611,620 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | X Exercise deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 305,810 | SEC↗ |
| IMDZ Immune Design Corp. | X Exercise deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 611,620 | — | $0 | 1,877,401 | SEC↗ |
| IMDZ Immune Design Corp. | S Sale | 2014-07-29 | 2014-07-31 | 208,334 | $12.00 | $2.50M | 1,974,877 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 2,183,211 | SEC↗ |
| IMDZ Immune Design Corp. | P Buy | 2014-07-29 | 2014-07-31 | 233,333 | $12.00 | $2.80M | 2,208,210 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 531,840 | — | $0 | 1,265,781 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 733,941 | — | $0 | 733,941 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2014-06-12 | 2014-06-16 | 12,414 | — | $0 | 12,414 | SEC↗ |
| VCYT VERACYTE, INC. | A Award deriv | 2014-05-20 | 2014-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2014-05-16 | 2014-05-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2014-03-27 | 2014-03-31 | 12,213 | — | $0 | 13,355 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $4.63 | $57.9K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 17,500 | $11.02 | $192.8K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $4.75 | $59.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $6.84 | $85.5K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 25,000 | $6.79 | $169.8K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $7.65 | $95.6K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $1.70 | $21.3K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 15,000 | $10.80 | $162.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 10,000 | $12.64 | $126.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 28,787 | $14.00 | $403.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 1,685,591 | $14.00 | $23.60M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 10,618 | $14.00 | $148.7K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 61,124 | $14.00 | $855.7K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 3,220,948 | $14.00 | $45.09M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2014-02-12 | 2014-02-21 | 690,816 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2014-02-12 | 2014-02-21 | 4,352 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | F Tax w/h | 2014-02-12 | 2014-02-21 | 386,857 | $14.00 | $5.42M | 1,685,591 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2014-02-12 | 2014-02-21 | 4,352 | $7.84 | $34.1K | 13,056 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | F Tax w/h | 2014-02-12 | 2014-02-21 | 2,438 | $14.00 | $34.1K | 10,618 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2014-02-12 | 2014-02-21 | 690,816 | $7.84 | $5.42M | 2,072,448 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 7,190,864 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 42,469 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 3,992,420 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 23,580 | — | $0 | 0 | SEC↗ |